The analyses in the 2017 Global Burden of Disease Study demonstrate the growing burden of chronic kidney disease (CKD), mainly driven by population ageing; absolute levels for every CKD metric considered rose significantly, whereas age-standardized rates were fairly stable. The prevalence of key metabolic CKD risk factors, particularly obesity, also show a worrying increase.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789–1858 (2018).
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1736–1788 (2018).
GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1859–1922 (2018).
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1923–1994 (2018).
Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–2040 for 195 countries and territories. Lancet 392, 2052–2090 (2018).
Jager, K. J. & Fraser, S. D. S. The ascending rank of CKD in the Global Burden of Disease study. Nephrol. Dial. Transplant. 32 (Suppl. 2), 121–128 (2017).
Brück, K. et al. CKD prevalence varies across the European general population. J. Am. Soc. Nephrol. 27, 2135–2147 (2016).
Tonelli, M. et al. Comparison of the complexity of patients seen by different medical subspecialists in a universal health care system. JAMA Netw. Open 1, e184852 (2018).
Pecoits-Filho, R. et al. Kidney disease in Latin America: current status, challenges and the role of ISN in the development of nephrology in the region. Kidney Int. 94, 1069–1072 (2018).
Bello, A. K. et al. Assessment of global kidney health care status. JAMA 317, 864–881 (2017).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Related links
GBD data visualization hub: https://vizhub.healthdata.org/gbd-compare/
Rights and permissions
About this article
Cite this article
Fraser, S.D.S., Roderick, P.J. Kidney disease in the Global Burden of Disease Study 2017. Nat Rev Nephrol 15, 193–194 (2019). https://doi.org/10.1038/s41581-019-0120-0
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41581-019-0120-0
